Loading insider details...
Beta
Latest Form 4 (Oct 13, 2026): Disposition to Issuer of 54 SNGX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 13, 2026 | SOLIGENIX, INC. (SNGX) | Disposition to Issuer | 54 | n/a |
| Sep 18, 2026 | SOLIGENIX, INC. (SNGX) | Grant/Award | 78,947 | n/a |
| May 20, 2026 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/Award | 5,750 | n/a |
| Jan 23, 2026 | Astria Therapeutics, Inc. (ATXS) | Disposition to Issuer | 16,666 | n/a |
| Jun 20, 2025 | SOLIGENIX, INC. (SNGX) | Grant/Award | 17,647 | n/a |
| Jun 12, 2025 | Astria Therapeutics, Inc. (ATXS) | Grant/Award | 26,550 | n/a |
| May 28, 2025 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/Award | 2,500 | n/a |
| Dec 13, 2024 | SOLIGENIX, INC. (SNGX) | Grant/Award | 8,646 | n/a |
| Jun 6, 2024 | Astria Therapeutics, Inc. (ATXS) | Grant/Award | 14,100 | n/a |
| May 29, 2024 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/Award | 25,000 | n/a |